|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Epstein-Barr Virus (VCA) IgG ELISA | BACE1 ELISA Assay | Complement System Classical Pathway ELISA Assay | Epstein-Barr Virus (EBNA-1) IgM ELISA | GPIHBP1 Autoantibody ELISA |
| Citations | | | | | |
| Catalog Number | IB79861 | 27752 | COMPL CP310 RUO | IB79860 | 27267 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Epstein-Barr Virus (VCA) IgG ELISA is intended for the determination of IgG class antibodies against Epstein-Barr Virus viral capsid antigen (VCA) in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of BACE1 in human, mouse or rat brain extracts or cultured cell lysate. For research use only, not for use in diagnostic procedures. | The Wieslab® COMPL CP310 is an enzyme immunoassay (ELISA) for the determination of functional classical complement pathway in human serum. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay for the determination of IgM-class antibodies to Epstein-Barr virus nuclear-1 antigen (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. | Indirect ELISA for the determination of human GPIHBP1 Autoantibody in serum, EDTA-plasma, heparin plasma, and post-heparin EDTA-plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Thioredoxin | CA 72-4 | Human Phopsho Tau (217P) | Schistosoma mansoni IgG | Progesterone |
| Sample Type | Serum, Blood Plasma, Urine, Cell Culture Supernatant | Serum, Blood Plasma | Cerebrospinal fluids | Serum, Blood Plasma | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 1.56 to 100 ng/mL | Inquire | A cut-off control is used for the interpretation of results. | 0 / 0.008 - 0.50 U/mL |
| Sensitivity | 0.43 ng/mL | 0.79 U/mL | 8.07 pg/mL | 93.75% (95% confidence interval: 82.8% - 98.69%) | 0.05 ng/mL |
| Assay Time | 1 hr, 45 mins (incubation) | 2 hrs (incubation) | 2 hrs (incubation) | 1 hr 45 mins (incubation) | 2 hour total incubation time. |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |